236 top medical experts on Mucocutaneous Leishmaniasis across 42 countries and 15 U.S. states, including 50 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Mucocutaneous Leishmaniasis: A disease characterized by the chronic, progressive spread of lesions from New World cutaneous leishmaniasis caused by species of the L. braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Cutaneous Leishmaniasis (3,248).
  4. Clinical Trials ClinicalTrials.gov : at least 8 including 5 Completed, 1 Recruiting


  

        

                    


    Computing Expert Listing ...

);